You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 12, December 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Neurological Review
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (36)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Encephalitis
 •Epilepsy
 •Dermatology
 •Connective Tissue Diseases
 •Rheumatology, Other
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Epilepsy and the Immune System

Johan A. Aarli, MD

Arch Neurol. 2000;57:1689-1692.

Objective  To discuss evidence that immune mechanisms are involved in the pathogenesis of some forms of epilepsy.

Data Sources  Computerized data sources and published indexes and articles.

Study Selection  Published reports showing disorders of the immune system in patients with epilepsy and in animals with experimental epilepsy.

Data Synthesis  Rasmussen encephalitis is an example of an autoimmune disorder of the central nervous system. Serum samples of patients with this disease contain antibodies to the glutamate receptor GluR3, and immunization of animals with GluR3 induces a disorder resembling the human disease. There are still few data to prove that immune mechanisms are involved in the pathogenesis of intractable childhood epilepsies other than Rasmussen encephalitis. Epilepsy is more common in patients with systemic lupus erythematosus who have antiphospholipid antibodies, and it is possible that these antibodies can lead to immune-mediated cortical damage. Immune defects in patients with epilepsy may occur as a consequence of long-term antiepileptic treatment or may represent a genetic coupling to the convulsive disorder.

Conclusion  The finding of an immunological basis may offer new modalities for the treatment of selected cases of intractable partial epilepsies.


From the Department of Neurology, University of Bergen, Haukeland Hospital, Bergen, Norway.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(12):1794-1795.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Epileptogenesis due to glia-mediated synaptic scaling
Savin et al.
J R Soc Interface 2009;6:655-668.
ABSTRACT | FULL TEXT  

Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex
Jamali et al.
Brain 2006;129:625-641.
ABSTRACT | FULL TEXT  

Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus
Mikdashi et al.
Neurology 2005;64:2102-2107.
ABSTRACT | FULL TEXT  

Cytokines and Seizures
Peltola et al.
Arch Neurol 2001;58:1168-1169.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.